Laidlaw Stock Recommendations and Price Targets

This is a list of recent ratings by Laidlaw.

Date	Company Name	Action	Current Price	Price Target	Rating	Impact on Share Price
3/18/2024	INAB IN8bio	Initiated Coverage	$1.00	$7.50	Buy	Low
12/22/2023	CING Cingulate	Downgrade	$1.00		Buy ➝ Hold	Low
12/13/2023	EVFM Evofem Biosciences	Reiterated Rating	$0.00		Buy ➝ Hold	Low
8/28/2023	SILO Silo Pharma	Initiated Coverage	$2.00	$10.00	Buy	Low
8/15/2023	TCRT Alaunos Therapeutics	Downgrade	$1.00		Buy ➝ Hold	Low
6/5/2023	BLPH Bellerophon Therapeutics	Downgrade	$0.00		Buy ➝ Hold	Low
5/9/2023	BLPH Bellerophon Therapeutics	Initiated Coverage	$0.00		Buy	Low
9/6/2022	NLSP NLS Pharmaceutics	Initiated Coverage	$0.00	$6.00	Buy	Low
6/2/2022	EVFM Evofem Biosciences	Initiated Coverage	$0.00	$437.50	Buy	High
1/20/2022	CING Cingulate	Initiated Coverage	$1.00	$170.00	Buy	High
9/13/2021	VINC Vincerx Pharma	Initiated Coverage	$1.00	$30.00	Buy	Low
5/10/2021	LIFE aTyr Pharma	Initiated Coverage	$2.00	$18.00	Buy	High